This inventor holds 9 USPTO granted patents and 16 published patent applications. Top assignee: Alpha Tau Medical Ltd.. Active years: 2024-2025.
Company Filing History:
Years Active: 2024-2025
Title: Maayan Hedva Vatarescu: Innovator in Radiation Therapy
Introduction
Maayan Hedva Vatarescu is a prominent inventor based in Lehavim, Israel. She has made significant contributions to the field of radiation therapy, particularly in the treatment of cancer. With a total of nine patents to her name, Vatarescu is recognized for her innovative approaches to medical technology.
Latest Patents
Vatarescu's latest patents include groundbreaking methods for treating prostate and colorectal cancers using diffusing alpha-emitter radiation therapy (DaRT). The patent for prostate cancer outlines a method that involves identifying a tumor as a prostate cancer tumor and implanting at least one DaRT source with a suitable radon release rate. This method ensures that the source provides a cumulated activity of released radon between 7 Mega becquerel (MBq) hour and 14.7 MBq hour per centimeter length. Additionally, her colorectal cancer patent describes a similar approach, where the DaRT source is implanted in a colorectal cancer tumor, providing a radon release rate between 3.7 MBq hour and 9.2 MBq hour per centimeter length.
Career Highlights
Vatarescu is currently associated with Alpha Tau Medical Ltd., a company dedicated to advancing cancer treatment technologies. Her work has positioned her as a key figure in the development of innovative therapies that aim to improve patient outcomes in oncology.
Collaborations
Some of her notable coworkers include Itzhak Kelson and Yona Keisari, who contribute to the collaborative efforts at Alpha Tau Medical Ltd. Their combined expertise enhances the research and development of effective cancer treatments.
Conclusion
Maayan Hedva Vatarescu's contributions to radiation therapy exemplify her commitment to innovation in medical technology. Her patents reflect a dedication to improving cancer treatment methodologies, making her a significant figure in the field.